328 related articles for article (PubMed ID: 20655388)
1. Pretransplant predictors and posttransplant sequels of acute kidney injury after allogeneic stem cell transplantation.
Kagoya Y; Kataoka K; Nannya Y; Kurokawa M
Biol Blood Marrow Transplant; 2011 Mar; 17(3):394-400. PubMed ID: 20655388
[TBL] [Abstract][Full Text] [Related]
2. Contemporary analysis of the influence of acute kidney injury after reduced intensity conditioning haematopoietic cell transplantation on long-term survival.
Lopes JA; Gonçalves S; Jorge S; Raimundo M; Resende L; Lourenço F; Lacerda JF; Martins C; do Carmo JA; Lacerda JM; Prata MM
Bone Marrow Transplant; 2008 Nov; 42(9):619-26. PubMed ID: 18622411
[TBL] [Abstract][Full Text] [Related]
3. Comparison of two pretransplant predictive models and a flexible HCT-CI using different cut off points to determine low-, intermediate-, and high-risk groups: the flexible HCT-CI Is the best predictor of NRM and OS in a population of patients undergoing allo-RIC.
Barba P; Piñana JL; Martino R; Valcárcel D; Amorós A; Sureda A; Briones J; Delgado J; Brunet S; Sierra J
Biol Blood Marrow Transplant; 2010 Mar; 16(3):413-20. PubMed ID: 19922807
[TBL] [Abstract][Full Text] [Related]
4. A comparative assessment of the RIFLE, AKIN and conventional criteria for acute kidney injury after hematopoietic SCT.
Ando M; Mori J; Ohashi K; Akiyama H; Morito T; Tsuchiya K; Nitta K; Sakamaki H
Bone Marrow Transplant; 2010 Sep; 45(9):1427-34. PubMed ID: 20062103
[TBL] [Abstract][Full Text] [Related]
5. [Early identification of acute kidney injury after hematopoietic stem cell transplantation by the measurement of urinary biomarkers].
Morito T; Ando M; Tsuchiya K; Nitta K
Nihon Jinzo Gakkai Shi; 2011; 53(8):1150-8. PubMed ID: 22351993
[TBL] [Abstract][Full Text] [Related]
6. Differential prognostic impact of pretransplant comorbidity on transplant outcomes by disease status and time from transplant: a single Japanese transplant centre study.
Kataoka K; Nannya Y; Ueda K; Kumano K; Takahashi T; Kurokawa M
Bone Marrow Transplant; 2010 Mar; 45(3):513-20. PubMed ID: 19684632
[TBL] [Abstract][Full Text] [Related]
7. Chronic kidney disease after myeloablative allogeneic hematopoietic stem cell transplantation.
Kersting S; Hené RJ; Koomans HA; Verdonck LF
Biol Blood Marrow Transplant; 2007 Oct; 13(10):1169-75. PubMed ID: 17889353
[TBL] [Abstract][Full Text] [Related]
8. Usefulness of the hematopoietic cell transplantation-specific comorbidity index (HCT-CI) in predicting outcomes for adolescents and young adults with hematologic malignancies undergoing allogeneic stem cell transplant.
Wood W; Deal A; Whitley J; Sharf A; Serody J; Gabriel D; Shea T
Pediatr Blood Cancer; 2011 Sep; 57(3):499-505. PubMed ID: 21384538
[TBL] [Abstract][Full Text] [Related]
9. A multicenter, retrospective study of acute kidney injury in adult patients with nonmyeloablative hematopoietic SCT.
Liu H; Li YF; Liu BC; Ding JH; Chen BA; Xu WL; Qian J
Bone Marrow Transplant; 2010 Jan; 45(1):153-8. PubMed ID: 19430501
[TBL] [Abstract][Full Text] [Related]
10. The hematopoietic cell transplantation comorbidity index (HCT-CI) predicts clinical outcomes in lymphoma and myeloma patients after reduced-intensity or non-myeloablative allogeneic stem cell transplantation.
Farina L; Bruno B; Patriarca F; Spina F; Sorasio R; Morelli M; Fanin R; Boccadoro M; Corradini P
Leukemia; 2009 Jun; 23(6):1131-8. PubMed ID: 19194465
[TBL] [Abstract][Full Text] [Related]
11. RIFLE-based data collection/management system applied to a prospective cohort multicenter Italian study on the epidemiology of acute kidney injury in the intensive care unit.
Garzotto F; Piccinni P; Cruz D; Gramaticopolo S; Dal Santo M; Aneloni G; Kim JC; Rocco M; Alessandri E; Giunta F; Michetti V; Iannuzzi M; Belluomo Anello C; Brienza N; Carlini M; Pelaia P; Gabbanelli V; Ronco C;
Blood Purif; 2011; 31(1-3):159-71. PubMed ID: 21228585
[TBL] [Abstract][Full Text] [Related]
12. Strong impact of acute kidney injury on survival after liver transplantation.
Zhu M; Li Y; Xia Q; Wang S; Qiu Y; Che M; Dai H; Qian J; Ni Z; Axelsson J; Yan Y
Transplant Proc; 2010 Nov; 42(9):3634-8. PubMed ID: 21094830
[TBL] [Abstract][Full Text] [Related]
13. A comparison of nonoliguric and oliguric severe acute kidney injury according to the risk injury failure loss end-stage (RIFLE) criteria.
Morgan DJ; Ho KM
Nephron Clin Pract; 2010; 115(1):c59-65. PubMed ID: 20173351
[TBL] [Abstract][Full Text] [Related]
14. Predictive value of RIFLE classification on prognosis of critically ill patients with acute kidney injury treated with continuous renal replacement therapy.
Li WX; Chen HD; Wang XW; Zhao S; Chen XK; Zheng Y; Song Y
Chin Med J (Engl); 2009 May; 122(9):1020-5. PubMed ID: 19493435
[TBL] [Abstract][Full Text] [Related]
15. Costs of hematopoietic cell transplantation: comparison of umbilical cord blood and matched related donor transplantation and the impact of posttransplant complications.
Majhail NS; Mothukuri JM; Brunstein CG; Weisdorf DJ
Biol Blood Marrow Transplant; 2009 May; 15(5):564-73. PubMed ID: 19361748
[TBL] [Abstract][Full Text] [Related]
16. Does the hematopoietic cell transplantation specific comorbidity index (HCT-CI) predict transplantation outcomes? A prospective multicenter validation study of the Kanto Study Group for Cell Therapy.
Nakaya A; Mori T; Tanaka M; Tomita N; Nakaseko C; Yano S; Fujisawa S; Sakamaki H; Aotsuka N; Yokota A; Kanda Y; Sakura T; Nanya Y; Saitoh T; Kanamori H; Takahashi S; Okamoto S
Biol Blood Marrow Transplant; 2014 Oct; 20(10):1553-9. PubMed ID: 25034961
[TBL] [Abstract][Full Text] [Related]
17. Impact of postgrafting immunosuppressive regimens on nonrelapse mortality and survival after nonmyeloablative allogeneic hematopoietic stem cell transplant using the fludarabine and low-dose total-body irradiation 200-cGy.
Koh LP; Chen CS; Tai BC; Hwang WY; Tan LK; Ng HY; Linn YC; Koh MB; Goh YT; Tan B; Lim S; Lee YM; Tan KW; Liu TC; Ng HJ; Loh YS; Mow BM; Tan DC; Tan PH
Biol Blood Marrow Transplant; 2007 Jul; 13(7):790-805. PubMed ID: 17580257
[TBL] [Abstract][Full Text] [Related]
18. Performance status, but not the hematopoietic cell transplantation comorbidity index (HCT-CI), predicts mortality at a Canadian transplant center.
Guilfoyle R; Demers A; Bredeson C; Richardson E; Rubinger M; Szwajcer D; Seftel MD
Bone Marrow Transplant; 2009 Jan; 43(2):133-9. PubMed ID: 18762762
[TBL] [Abstract][Full Text] [Related]
19. Allogeneic stem cell transplantation for adults with myelodysplastic syndromes: importance of pretransplant disease burden.
Warlick ED; Cioc A; Defor T; Dolan M; Weisdorf D
Biol Blood Marrow Transplant; 2009 Jan; 15(1):30-8. PubMed ID: 19135940
[TBL] [Abstract][Full Text] [Related]
20. [Prognostic implications of hematopoietic cell transplantation-specific comorbidity index on non-relapse mortality and overall survival after allogeneic hematopoietic stem cell transplantation].
Wang CY; Ren HY; Qiu ZX; Wang Y; Cen XN; Wang LH; Wang MJ; Xu WL; Wang WS; Li Y; Dong YJ; Ou JP; Liang ZY; Liu W; Wang Q
Zhonghua Xue Ye Xue Za Zhi; 2013 Aug; 34(8):659-63. PubMed ID: 23978015
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
